Actively Recruiting

Phase Not Applicable
Age: 18Years - 90Years
All Genders
ID06946498

Local Anesthesia Thoracoscopy as a First Line Approach in the Diagnosis of Suspected Malignant Pleural Effusion: FLAT Trial.

Led by National and Kapodistrian University of Athens · Updated on 2025-04-27

100

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

Sponsors

N

National and Kapodistrian University of Athens

Lead Sponsor

S

Sotiria Thoracic Diseases Hospital of Athens

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating diagnostic approaches for patients with unexplained lymphocytic pleural effusion suspected to be malignant. The study compares two groups: one undergoing immediate Local Anesthesia Thoracoscopy (LAT) for pleural biopsy and the other receiving the standard diagnostic care involving multiple pleural fluid cytological tests followed by biopsy if needed. The goal is to assess the effectiveness, sensitivity, hospitalization duration, and safety between these methods. Patients in the study group receive LAT under conscious sedation, where local anesthesia is applied and biopsy samples are taken through a thoracoscope. This procedure also allows for therapeutic pleurodesis if needed. The control group is managed with standard care, including at least three pleural fluid cytology samples and other diagnostic tests, with biopsy referrals made if diagnosis remains uncertain. Both groups undergo imaging and laboratory evaluations as clinically indicated. Participants are monitored for time to diagnosis and hospital stay length, with assessments extending up to 12 months for diagnosis and 3 months for hospitalization. Additional evaluations include patient discomfort and pain immediately post-procedure and daily until chest tube removal or discharge, as well as monitoring for complications and rates of non-specific pleuritis. Follow-up includes chest X-rays and clinical evaluations, ensuring comprehensive safety and outcome tracking during the study period.

CONDITIONS

Brief Title

First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.

Who Can Participate

Age: 18Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Undiagnosed pleural effusion with the character of a lymphocytic exudate
  • Age between 18 and 90 years
  • Both men and women are eligible
Not Eligible

You will not qualify if you...

  • Empyema
  • Transudate pleural effusion
  • Central airway obstruction by tumor
  • Extensive adhesions preventing safe thoracoscope entry
  • Uncontrollable cough
  • Acute respiratory failure and/or hypercapnia
  • Performance Status of 5

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 12 months

Participants undergo diagnostic procedures to determine the cause of pleural effusion. The LAT Group will have Local Anesthesia Thoracoscopy as the first diagnostic approach, while the Control Group will follow the standard of care involving multiple fluid cytology samples and other tests before biopsy if needed.

Multiple visits depending on diagnostic procedures and clinical assessment

Post-procedure Monitoring

Duration - Up to 2 weeks for pain assessment and chest tube removal; complications monitored up to 3 months

Participants are monitored for pain, complications, and recovery after diagnostic procedures including thoracoscopy and chest tube management.

Daily visits during chest tube management and follow-up visits as needed up to 3 months

Trial Site Locations

Total: 1 location

1

Sotiria General Hospital of Thoracic Diseases

Athens, Attica, Greece, 11527

Actively Recruiting

Loading map...

Research Team

N

Nektarios ANAGNOSTOPOULOS, Ass. professor

M

Michail Kon/nos Tsatsis, MD, MSc, PhDc

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Similar Trials

ICARuS II Trial: Comparing Intraperitoneal and Intravenous C...

Malignant Peritoneal Mesothelioma

Actively Recruiting

13 locations

A Phase 1/2 Study of Tulmimetostat (DZR123, CPI-0209) in Pat...

Advanced Solid Tumor

Actively Recruiting

60 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Staging by Thoracoscopy in potentially radically treatable Lung Cancer associated with Minimal Pleural Effusion (STRATIFY): protocol of a prospective, multicentre, observational study.

Jenny Ferguson, Selina Tsim, Caroline Kelly...

https://pubmed.ncbi.nlm.nih.gov/37996118